IBDEI0S6 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13610,0)
 ;;=210.0^^71^806^13
 ;;^UTILITY(U,$J,358.3,13610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13610,1,3,0)
 ;;=3^BEN NEO LIP
 ;;^UTILITY(U,$J,358.3,13610,1,4,0)
 ;;=4^210.0
 ;;^UTILITY(U,$J,358.3,13610,2)
 ;;=^267578
 ;;^UTILITY(U,$J,358.3,13611,0)
 ;;=701.9^^71^806^136
 ;;^UTILITY(U,$J,358.3,13611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13611,1,3,0)
 ;;=3^SKIN HYPERTRO/ATROPH NOS
 ;;^UTILITY(U,$J,358.3,13611,1,4,0)
 ;;=4^701.9
 ;;^UTILITY(U,$J,358.3,13611,2)
 ;;=^123929
 ;;^UTILITY(U,$J,358.3,13612,0)
 ;;=756.83^^71^806^46
 ;;^UTILITY(U,$J,358.3,13612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13612,1,3,0)
 ;;=3^EHLERS-DANLOS SYNDROME
 ;;^UTILITY(U,$J,358.3,13612,1,4,0)
 ;;=4^756.83
 ;;^UTILITY(U,$J,358.3,13612,2)
 ;;=^38754
 ;;^UTILITY(U,$J,358.3,13613,0)
 ;;=V50.1^^71^806^121
 ;;^UTILITY(U,$J,358.3,13613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13613,1,3,0)
 ;;=3^PLASTIC SURGERY NEC
 ;;^UTILITY(U,$J,358.3,13613,1,4,0)
 ;;=4^V50.1
 ;;^UTILITY(U,$J,358.3,13613,2)
 ;;=^87802
 ;;^UTILITY(U,$J,358.3,13614,0)
 ;;=709.2^^71^806^128
 ;;^UTILITY(U,$J,358.3,13614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13614,1,3,0)
 ;;=3^SCAR FIBROSIS OF SKIN
 ;;^UTILITY(U,$J,358.3,13614,1,4,0)
 ;;=4^709.2
 ;;^UTILITY(U,$J,358.3,13614,2)
 ;;=^108131
 ;;^UTILITY(U,$J,358.3,13615,0)
 ;;=216.9^^71^806^16
 ;;^UTILITY(U,$J,358.3,13615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13615,1,3,0)
 ;;=3^BEN NEO SKIN NOS
 ;;^UTILITY(U,$J,358.3,13615,1,4,0)
 ;;=4^216.9
 ;;^UTILITY(U,$J,358.3,13615,2)
 ;;=^13314
 ;;^UTILITY(U,$J,358.3,13616,0)
 ;;=528.5^^71^806^75
 ;;^UTILITY(U,$J,358.3,13616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13616,1,3,0)
 ;;=3^LIP DISEASE
 ;;^UTILITY(U,$J,358.3,13616,1,4,0)
 ;;=4^528.5
 ;;^UTILITY(U,$J,358.3,13616,2)
 ;;=^70993
 ;;^UTILITY(U,$J,358.3,13617,0)
 ;;=709.9^^71^806^134
 ;;^UTILITY(U,$J,358.3,13617,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13617,1,3,0)
 ;;=3^SKIN DISORDER NOS
 ;;^UTILITY(U,$J,358.3,13617,1,4,0)
 ;;=4^709.9
 ;;^UTILITY(U,$J,358.3,13617,2)
 ;;=^111083
 ;;^UTILITY(U,$J,358.3,13618,0)
 ;;=140.9^^71^806^80
 ;;^UTILITY(U,$J,358.3,13618,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13618,1,3,0)
 ;;=3^MAL NEO LIP/VERMIL NOS
 ;;^UTILITY(U,$J,358.3,13618,1,4,0)
 ;;=4^140.9
 ;;^UTILITY(U,$J,358.3,13618,2)
 ;;=^266994
 ;;^UTILITY(U,$J,358.3,13619,0)
 ;;=903.5^^71^806^64
 ;;^UTILITY(U,$J,358.3,13619,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13619,1,3,0)
 ;;=3^INJURY FINGER VESSELS
 ;;^UTILITY(U,$J,358.3,13619,1,4,0)
 ;;=4^903.5
 ;;^UTILITY(U,$J,358.3,13619,2)
 ;;=^275191
 ;;^UTILITY(U,$J,358.3,13620,0)
 ;;=904.8^^71^806^66
 ;;^UTILITY(U,$J,358.3,13620,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13620,1,3,0)
 ;;=3^INJURY LEG VESSEL NOS
 ;;^UTILITY(U,$J,358.3,13620,1,4,0)
 ;;=4^904.8
 ;;^UTILITY(U,$J,358.3,13620,2)
 ;;=^275211
 ;;^UTILITY(U,$J,358.3,13621,0)
 ;;=903.9^^71^806^61
 ;;^UTILITY(U,$J,358.3,13621,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13621,1,3,0)
 ;;=3^INJURY ARM VESSEL NOS
 ;;^UTILITY(U,$J,358.3,13621,1,4,0)
 ;;=4^903.9
 ;;^UTILITY(U,$J,358.3,13621,2)
 ;;=^275193
 ;;^UTILITY(U,$J,358.3,13622,0)
 ;;=955.9^^71^806^60
 ;;^UTILITY(U,$J,358.3,13622,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13622,1,3,0)
 ;;=3^INJ NERVE SHLDR/ARM NOS
 ;;^UTILITY(U,$J,358.3,13622,1,4,0)
 ;;=4^955.9
 ;;^UTILITY(U,$J,358.3,13622,2)
 ;;=^275961
 ;;^UTILITY(U,$J,358.3,13623,0)
 ;;=955.6^^71^806^62
 ;;^UTILITY(U,$J,358.3,13623,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13623,1,3,0)
 ;;=3^INJURY DIGITAL NERVE
 ;;^UTILITY(U,$J,358.3,13623,1,4,0)
 ;;=4^955.6
 ;;
 ;;$END ROU IBDEI0S6
